Smart science to improve lives™
Open search Basket 0 View basket

Speak with an expert

CAF09b®

A novel liposomal adjuvant used in cancer immunotherapy trials, CAF09b has the capacity to facilitate the production of CD8+ T-cells.

indicates required field
Please provide your first name
Please provide your last name
Please provide an email address
+44
Please enter your phone number
Please provide your company name
Please complete the recaptcha and resubmit the form.